Maximum proton kinetic energy and patient-generated neutron fluence considerations in proton beam arc delivery radiation therapy

Medical Physics

Volumn 36, Issue 2, 2009, Pages 364-372

  Sengbusch, E ^a   Perez Andujar A ^a   DeLuca, P M ^a   Mackie, T R ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Neutron production; Proton therapy; Radiation therapy; Rotational therapy

Indexed keywords

ACCELERATION; COST ENGINEERING; INTELLIGENT SYSTEMS; KINETICS; MONTE CARLO METHODS; NEUTRON IRRADIATION; NEUTRONS; PARTICLE ACCELERATORS; PHANTOMS; PROTON BEAM THERAPY; PROTON BEAMS; RADIOTHERAPY;

ACCELERATOR SYSTEM; ENERGY THRESHOLDS; NEUTRON FLUENCES; NEUTRON PRODUCTION; PROTON KINETIC ENERGIES; PROTON THERAPY; ROTATIONAL THERAPY; TREATMENT SYSTEMS; WATER PHANTOM;

KINETIC ENERGY;

PROTON;

ARTICLE; ENERGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KINETICS; MAJOR CLINICAL STUDY; MONTE CARLO METHOD; NEUTRON RADIATION; PRIORITY JOURNAL; PROTON THERAPY; PROTON TRANSPORT; TREATMENT PLANNING;

EID: 59249104297     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3049787     Document Type: Article

References (35)

1. R. J. Shulz, A. R. Smith, and C. G. Orton, " Point/counterpoint. Proton therapy is too expensive for the minimal potential improvements in outcome claimed.," Med. Phys. 34, 1135-1138 (2007).
2. H. Suit, H. Kooy, A. Trofimov, J. Farr, J. Munzenrider, T. Delaney, J. Loeffler, B. Clasie, S. Safai, and H. Paganetti, " Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.," Radiother. Oncol. 86, 148-153 (2008).
3. M. Goitein and M. Jermann, " The relative costs of proton and x-ray radiation therapy.," Clin. Oncol. 15, S37-S50 (2003).
4. V. Malka, S. Fritzler, E. Lefebvre, E. d'Humieres, R. Ferrand, G. Grillon, C. Albaret, S. Meyroneinc, J. P. Chambaret, A. Antonetti, and D. Hulin, " Practicability of protontherapy using compact laser systems.," Med. Phys. 31, 1587-1592 (2004).
5. C. C. Ma and R. L. Maughan, " Within the next decade conventional cyclotrons for proton radiotherapy will become obsolete and replaced by far less expensive machines using compact laser systems for the acceleration of protons.," Med. Phys. 33, 571-573 (2006).
6. A. R. Smith, " Proton therapy.," Phys. Med. Biol. 51, R491-R504 (2006).
7. S. E. Sampayan, P. A. Vitello, M. L. Krogh, and J. M. Elizondo, " Multilayer high gradient insulator technology.," IEEE Trans. Dielectr. Electr. Insul. 7, 334-339 (2000).
8. Y. Jongen, W. Beeckman, and P. Cohilis, " The proton therapy system for MGH's NPTC: Equipment description and progress report.," Bull. Cancer Radiother 83, 219s-222s (1996).
9. ICRU, " Stopping powers for protons and alpha particles.," ICRU Report 49 (ICRU, Bethesda, MD, 1993).
10. M. Goiten, R. Gentry, and A. M. Koehler, " Energy of proton accelerator necessary for treatment of choroidal melanomas.," Int. J. Radiat. Oncol., Biol., Phys. 9, 259-260 (1983).
11. M. F. Moyers and D. W. Miller, " Range, range modulation and field radius requirements for proton therapy of prostate cancer.," Technol. Cancer Res. Treat. 2, 445-447 (2003).
12. K. A. Mason, M. T. Gillin, R. Mohan, and J. D. Cox, " Preclinical biologic assessment of proton beam relative biologic effectiveness at proton therapy center houston.," Int. J. Radiat. Oncol., Biol., Phys. 68, 968-970 (2007).
13. Y. Jongen, W. Beeckman, and P. Cohilis, " The proton therapy system for MGH's NPTC: Equipment description and progress report.," Bull. Cancer Radiother 83, 219s-222s (1996).
14. G. B. Coutrakon, " Accelerators for heavy-charged-particle radiation therapy.," Technol. Cancer Res. Treat. 6, Suppl. 49-54 (2007).
15. V. Anferov, " Combined X-Y scanning magnet for conformal proton radiation therapy.," Med. Phys. 32, 815-818 (2005).
16. J. O. Deasy, D. Shepard, and T. R. Mackie, " Distal edge tracking: A proposed delivery method for conformal proton therapy using intensity modulation.," in Proceedings of the 12th International Conference on the use of Computer in Radiation Therapy (ICCR), Salt Lake City, UT, (1997).
17. R. T. Flynn, D. L. Barbee, T. R. Mackie, and R. Jeraj, " Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study.," Phys. Med. Biol. 52, 6073-6091 (2007).
18. B. Schaffner and E. Pedroni, " The precision of proton range calculations in proton radiotherapy treatment planning: Experimental verification of the relation between CT-HU and proton stopping power.," Phys. Med. Biol. 43, 1579-1592 (1998).
19. J. V. Siebers, P. M. DeLuca, Jr., and D. W. Pearson, " Shielding calculations for 230 MeV protons using the LAHET code system.," Nucl. Sci. Eng. 122, 258-266 (1996).
20. J. H́rault, N. Iborra, B. Serrano, and P. Chauvel, " Monte Carlo simulations of a proton therapy platform devoted to ocular melanoma.," Med. Phys. 32, 910-919 (2005).
21. N. Koch and W. D. Newhauser, " Virtual commissioning of a treatment planning system for proton therapy of ocular cancers.," Radiat. Prot. Dosim. 115, 159-163 (2005).
22. J. D. Fontenot, W. D. Newhauser, and U. Titt, " Design tools for the proton therapy nozzles based on the double scattering foil technique.," Radiat. Prot. Dosim. 116, 211-215 (2005).
23. W. Newhauser, J. Fontenot, Y. Zheng, J. Polf, U. Titt, N. Koch, X. Zhang, and R. Mohan, " Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm.," Phys. Med. Biol. 52, 4569-4584 (2007).
24. U. Titt and W. D. Newhauser, " Neutron shielding calculations in a proton therapy facility based on Monte Carlo simulations and analytical models: Criterion for selecting the method of choice.," Radiat. Prot. Dosim. 115, 144-148 (2005).
25. N. Koch, W. Newhauser, U. Titt, D. Gombos, K. Coombes, and G. Starkschall, " Calculations and measurements of proton absorbed dose per monitor unit for the treatment of uveal melanoma.," Phys. Med. Biol. 53, 1581-1594 (2008).
26. M. Majerle, " Experimental studies and simulations of spallation neutron production on a thick lead target.," J. Phys.: Conf. Ser. 41, 331-339 (2006).
27. J. R. Lebenhaft, R. Früh, and R. Chawla, " The effect of nuclear data on the MCNPX modeling of moderator level variations in the CROCUS critical facility.," J. Nucl. Sci. Technol. 40, 429-432 (2003).
28. D-5 MCNPX Development Team, MCNPX-Monte Carlo N-Particle eXtended, MCNPX user's manual, Version 2.5.0, Report LA-CP-05-0369, Los Alamos National Laboratory (2005).
29. H. W. Bertini, " Low-energy intranuclear cascade calculation.," Phys. Rev. 131, 1801-1821 (1963).
30. M. B. Chadwick, " Cross-section evaluations to 150 MeV for accelerator-driven systems implementation in MCNPX.," Nucl. Sci. Eng. 131, 293-328 (1999).
31. A. Bradl, C. Hranitzky, and S. Rollet, " Shielding variation effects for 250 MeV protons on tissue targets.," Radiat. Prot. Dosim. 115, 195-199 (2005).
32. W. K. Hagan, B. L. Colborn, and T. W. Armstrong, " Radiation shielding calculations for a 70 to 250 MeV proton therapy facility.," Nucl. Sci. Eng. 98, 272-278 (1988).
33. R. G. Alsmiller, Jr., R. T. Santoro, and J. Barish, " Shielding calculations for a 200-MeV proton accelerator and comparison with experimental data.," Part. Accel. 7, 1-7 (1975).
34. S. Agosteo, M. Magistris, A. Mareghetti, M. Silari, and Z. Zajacova, " Shielding data for 100-250 MeV proton accelerators: Double differential neutron distribution and attenuation in concrete.," Nucl. Instrum. Methods Phys. Res. B 265, 581-598 (2007).
35. J. V. Siebers, P. M. DeLuca, Jr., D. W. Pearson, and G. Countrakon, " Measurement of neutron dose equivalent and penetration in concrete for 230 MeV proton bombardment of Al, Fe and Pb targets.," Radiat. Prot. Dosim. 44, 247-251 (1992).